Patient Preference for Optical Coherence Tomography versus Punch Biopsy as Diagnostic Strategy for Diagnosis of Basal Cell Carcinoma: A Labelled Discrete Choice Experiment
DOI:
https://doi.org/10.2340/actadv.v101.977Keywords:
Discrete Choice Experiment, choice experiment, patient preferences, Optical Coherence Tomography, basal cell carcinoma, punch biopsyAbstract
Abstract is missing (Short communication)
Downloads
References
Peris K, Fargnoli MC, Garbe C, Kaufmann R, Bastholt L, Seguin NB, et al. Diagnosis and treatment of basal cell carcinoma: European consensus-based interdisciplinary guidelines. Eur J Cancer 2019; 118: 10-34.
https://doi.org/10.1016/j.ejca.2019.06.003 DOI: https://doi.org/10.1016/j.ejca.2019.06.003
Kim JYS, Kozlow JH, Mittal B, Moyer J, Olencki T, Rodgers P. Guidelines of care for the management of basal cell carcinoma. Work Group. J Am Acad Dermatol 2018; 78: 540-559.
https://doi.org/10.1016/j.jaad.2017.10.006 DOI: https://doi.org/10.1016/j.jaad.2017.10.006
Sinx KAE, van LE, Tonk EHJ, Kelleners-Smeets NWJ, Winnepenninckx VJL, Nelemans PJ, et al. Optical coherence tomography for noninvasive diagnosis and subtyping of basal cell carcinoma: a prospective cohort study. J Invest Dermatol 2020; 140: 1962-1967.
https://doi.org/10.1016/j.jid.2020.01.034 DOI: https://doi.org/10.1016/j.jid.2020.01.034
Markowitz O, Schwartz M, Feldman E, Bienenfeld A, Bieber AK, Ellis J, et al. Evaluation of optical coherence tomography as a means of identifying earlier stage basal cell carcinomas while reducing the use of diagnostic biopsy. J Clin Aesthet Dermatol 2015; 8: 14-20.
Ulrich M, von Braunmuehl T, Kurzen H, Dirschka T, Kellner C, Sattler E, et al. The sensitivity and specificity of optical coherence tomography for the assisted diagnosis of nonpigmented basal cell carcinoma: an observational study. Br J Dermatol 2015; 173: 428-435.
https://doi.org/10.1111/bjd.13853 DOI: https://doi.org/10.1111/bjd.13853
Kadouch DJ, Leeflang MM, Elshot YS, Longo C, Ulrich M, van der Wal AC, et al. Diagnostic accuracy of confocal microscopy imaging vs. punch biopsy for diagnosing and subtyping basal cell carcinoma. J Eur Acad Dermatol Venereol 2017; 31: 1641-1648.
https://doi.org/10.1111/jdv.14253 DOI: https://doi.org/10.1111/jdv.14253
Mogensen M, Joergensen TM, Nurnberg BM, Morsy HA, Thomsen JB, Thrane L, et al. Assessment of optical coherence tomography imaging in the diagnosis of non-melanoma skin cancer and benign lesions versus normal skin: observer-blinded evaluation by dermatologists and pathologists. Dermatol Surg 2009; 35: 965-972.
https://doi.org/10.1111/j.1524-4725.2009.01164.x DOI: https://doi.org/10.1111/j.1524-4725.2009.01164.x
Ferreira-Valente MA, Pais-Ribeiro JL, Jensen MP. Validity of four pain intensity rating scales. Pain 2011; 152: 2399-2404.
https://doi.org/10.1016/j.pain.2011.07.005 DOI: https://doi.org/10.1016/j.pain.2011.07.005
Schaarschmidt ML, Herr R, Gutknecht M, Wroblewska K, Gerdes S, Sticherling M, et al. Patients' and physicians' preferences for systemic psoriasis treatments: a nationwide comparative discrete choice experiment (PsoCompare). Acta Derm Venereol 2018; 98: 200-205.
https://doi.org/10.2340/00015555-2834 DOI: https://doi.org/10.2340/00015555-2834
Tinelli M, Ozolins M, Bath-Hextall F, Williams HC. What determines patient preferences for treating low risk basal cell carcinoma when comparing surgery vs imiquimod? A discrete choice experiment survey from the SINS trial. BMC Dermatol 2012; 12: 19.
https://doi.org/10.1186/1471-5945-12-19 DOI: https://doi.org/10.1186/1471-5945-12-19
Essers BAB, Arits AH, Hendriks MR, Mosterd K, Kelleners-Smeets NW. Patient preferences for the attributes of a noninvasive treatment for superficial basal cell carcinoma: a discrete choice experiment. Br J Dermatol 2018; 178: e26-e27.
https://doi.org/10.1111/bjd.15782 DOI: https://doi.org/10.1111/bjd.15782
Published
How to Cite
License
Copyright (c) 2021 Fieke Adan, Klara Mosterd, Tom Wolswijk, Nicole W.J. Kelleners-Smeets, Brigitte A.B. Essers
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
All digitalized ActaDV contents is available freely online. The Society for Publication of Acta Dermato-Venereologica owns the copyright for all material published until volume 88 (2008) and as from volume 89 (2009) the journal has been published fully Open Access, meaning the authors retain copyright to their work.
Unless otherwise specified, all Open Access articles are published under CC-BY-NC licences, allowing third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material for non-commercial purposes, provided proper attribution to the original work.
